Valeant Pharmaceuticals International Inc. has acquired Mercury (Cayman) Holdings, the holding company of Amoun Pharmaceutical, for approximately $800 million, plus contingent payments. Amoun Pharmaceutical is the largest domestic company in the Egyptian pharmaceutical market and currently expects to reach EGP 1.75 billion by 2015, with annual growth of approximately 20%. Amoun operates a large, state-of-the-art manufacturing plant that is considered to be one of the largest and most up-to-da...